Study of Benzofuroquinolinium Derivatives as a New Class of Potent Antibacterial Agent and the Mode of Inhibition Targeting FtsZ

Frontiers in Microbiology
Yuan-Yuan ZhengKwok-Yin Wong

Abstract

New generation of antibacterial agents are urgently needed in order to fight the emergence of multidrug-resistant bacteria. FtsZ is currently identified as a promising target for new types of antimicrobial compounds development because of its conservative characteristics and its essential role played in bacterial cell division. In the present study, the antibacterial activity of a series of benzofuroquinolinium derivatives was investigated. The results show that the compounds possess potent antibacterial activity against drug resistant pathogens including MRSA, VREF and NDM-1 Escherichia coli. Biological studies reveal that the compound is an effective inhibitor that is able to suppress FtsZ polymerization and GTPase activity and thus stopping the cell division and causing cell death. More importantly, this series of compounds shows low cytotoxicity on mammalian cells and therefore they could be new chemotypes for the development of new antibacterial agents targeting the cell-division protein FtsZ.

References

Aug 1, 1993·Molecular Microbiology·J Lutkenhaus
Aug 4, 2004·Proceedings of the National Academy of Sciences of the United States of America·Danielle N MargalitDebabrata RayChaudhuri
Dec 4, 2004·Nature Medicine·Stuart B Levy, Bonnie Marshall
Oct 18, 2005·Nature Reviews. Molecular Cell Biology·William Margolin
Jul 31, 2007·Biochemical Pharmacology·Prerna DomadiaDebjani Dasgupta
Feb 16, 2008·Biochemistry·Prerna N DomadiaDebjani Dasgupta
Mar 8, 2008·Nature Reviews. Drug Discovery·Rowena L Lock, Elizabeth J Harry
Sep 20, 2008·Science·David J Payne
Sep 20, 2008·Science·David J HaydonLloyd G Czaplewski
Aug 8, 2009·Expert Opinion on Therapeutic Targets·Sonia Kapoor, Dulal Panda
Aug 29, 2009·Science·Michael A Fischbach, Christopher T Walsh
Mar 10, 2010·The Journal of Biological Chemistry·José M AndreuAntonio J Martín-Galiano
Jun 12, 2010·Journal of the American Chemical Society·Alberto PlazaCarole A Bewley
Mar 25, 2011·Chemical Communications : Chem Comm·Yu-Jing LuKwok-Yin Wong
Jun 29, 2011·FEMS Microbiology Reviews·Hiroshi Nikaido, Jean-Marie Pagès
Jul 16, 2013·Journal of Chemical Information and Modeling·Fung-Yi ChanKwok-Yin Wong
Jul 17, 2013·ACS Chemical Biology·Laura B Ruiz-AvilaJosé M Andreu
Aug 13, 2013·Bioorganic & Medicinal Chemistry·Jessica L KefferCarole A Bewley
Nov 30, 2013·Bioorganic & Medicinal Chemistry Letters·Neil R StokesDavid J Haydon
Apr 23, 2014·Biochemistry·Dipty SinghDulal Panda
Dec 2, 2014·Nature Reviews. Microbiology·Jessica M A BlairLaura J V Piddock
Feb 24, 2015·Frontiers in Microbiology·Jun LinLixin Zhang
Jan 13, 2016·Journal of Medicinal Chemistry·Katherine Ann HurleyDouglas B Weibel
May 18, 2016·Bioorganic & Medicinal Chemistry·Krupanandan HaranahalliIwao Ojima
Nov 12, 2016·European Journal of Medicinal Chemistry·Mi YanShutao Ma
May 10, 2017·Antimicrobial Agents and Chemotherapy·Zhaojun ZhengEleftherios Mylonakis
Dec 9, 2017·European Journal of Medicinal Chemistry·Yinhu WangHenrietta Venter
May 4, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·Ning SunKwok-Yin Wong

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase
Assay
X-ray
NMR

Software Mentioned

Image J
CDOCKER
Discovery Studio

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.